Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016 - GlobalData

Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016

Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016 - GlobalData
Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016
Published Nov 01, 2016
96 pages — Published Nov 01, 2016
Price US$ 2,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's Medical Devices sector report, Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016' provides an overview of Vagus Nerve Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vagus Nerve Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Vagus Nerve Stimulators under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vagus Nerve Stimulators and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vagus Nerve Stimulators under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

  
Source:
Document ID
GDME0250EPD
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents25
  1.1 List of Tables42
  1.2 List of Figures61
2 Introduction71
  2.1 Vagus Nerve Stimulators Overview71
3 Products under Development85
  3.1 Vagus Nerve Stimulators - Pipeline Products by Stage of Development81
  3.2 Vagus Nerve Stimulators - Pipeline Products by Territory91
  3.3 Vagus Nerve Stimulators - Pipeline Products by Regulatory Path101
  3.4 Vagus Nerve Stimulators - Pipeline Products by Estimated Approval Date111
  3.5 Vagus Nerve Stimulators - Ongoing Clinical Trials121
4 Vagus Nerve Stimulators - Pipeline Products under Development by Companies132
  4.1 Vagus Nerve Stimulators Companies - Pipeline Products by Stage of Development131
  4.2 Vagus Nerve Stimulators - Pipeline Products by Stage of Development141
5 Vagus Nerve Stimulators Companies and Product Overview1542
  5.1 BioControl Medical Company Overview151
    5.1.1 BioControl Medical Pipeline Products &Ongoing Clinical Trials Overview152
  5.2 Boston Scientific Corporation Company Overview171
    5.2.1 Boston Scientific Corporation Pipeline Products &Ongoing Clinical Trials Overview174
  5.3 CerboMed GmbH Company Overview211
    5.3.1 CerboMed GmbH Pipeline Products &Ongoing Clinical Trials Overview211
  5.4 Cerebral RX Ltd. Company Overview221
    5.4.1 Cerebral RX Ltd. Pipeline Products &Ongoing Clinical Trials Overview221
  5.5 Cyberonics, Inc. Company Overview231
    5.5.1 Cyberonics, Inc. Pipeline Products &Ongoing Clinical Trials Overview234
  5.6 DuoCure Ltd. Company Overview271
    5.6.1 DuoCure Ltd. Pipeline Products &Ongoing Clinical Trials Overview271
  5.7 ElectroCore, LLC Company Overview281
    5.7.1 ElectroCore, LLC Pipeline Products &Ongoing Clinical Trials Overview286
  5.8 LivaNova PLC Company Overview341
    5.8.1 LivaNova PLC Pipeline Products &Ongoing Clinical Trials Overview346
  5.9 Medical University of South Carolina Company Overview401
    5.9.1 Medical University of South Carolina Pipeline Products &Ongoing Clinical Trials Overview402
  5.10 MicroTransponder Inc. Company Overview421
    5.10.1 MicroTransponder Inc. Pipeline Products &Ongoing Clinical Trials Overview427
  5.11 Neurostream Technologies G.P. (Inactive) Company Overview491
    5.11.1 Neurostream Technologies G.P. (Inactive) Pipeline Products &Ongoing Clinical Trials Overview492
  5.12 Purdue University Company Overview511
    5.12.1 Purdue University Pipeline Products &Ongoing Clinical Trials Overview511
  5.13 Setpoint Medical Corp Company Overview521
    5.13.1 Setpoint Medical Corp Pipeline Products &Ongoing Clinical Trials Overview524
  5.14 Trifectas Medical Corp. Company Overview561
    5.14.1 Trifectas Medical Corp. Pipeline Products &Ongoing Clinical Trials Overview561
6 Vagus Nerve Stimulators- Recent Developments5736
  6.1 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016571
  6.2 Oct 19, 2016: SetPoint Medical Presents Positive Clinical Results in Crohn s Disease581
  6.3 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results591
  6.4 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer601
  6.5 Sep 29, 2016: LivaNova Announces Half-Year Financial Report618
  6.6 Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results691
  6.7 Aug 01, 2016: LivaNova Names Chief Operating Officer701
  6.8 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016711
  6.9 Jul 26, 2016: Use of electroCore s therapy reduces frequency of migraine attacks in chronic patients721
  6.10 Jul 21, 2016: Reorganization of electroCore management team as Frank Amato becomes CEO and founder JP Errico becomes Chief Science and Strategy Officer731
  6.11 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results732
  6.12 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors751
  6.13 Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization751
  6.14 Jul 05, 2016: Breakthrough First-in-Human Study Shows Vagus Nerve Stimulation Significantly Reduces Rheumatoid Arthritis Symptoms, Inhibits Cytokine Production761
  6.15 Jun 29, 2016: ElectroCore Raises USD1.5 Million in Venture Financing771
  6.16 Jun 24, 2016: Five presentations at AHS meeting provide new insights into non-invasive vagus nerve stimulation s mode of action771
  6.17 Jun 15, 2016: ElectroCore s non-invasive vagus nerve stimulation (nVNS) demonstrates efficacy in preventing cluster headache and menstrual migraine781
  6.18 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation781
  6.19 Jun 06, 2016: Seven presentations on electroCore s treatment for cluster headache and migraine will feature at American Headache Society science meeting791
  6.20 May 31, 2016: Ergoresearch announce the nomination of an Executive Vice-President801
  6.21 May 27, 2016: Ergoresearch Reports its Results for the Quarter Ended March 31, 2016811
  6.22 May 17, 2016: GammaCore is both effective and cost effective for the treatment of cluster headache811
  6.23 May 04, 2016: LivaNova Reports First Quarter 2016 Results821
  6.24 Apr 19, 2016: Studies presented at the American Academy of Neurology meeting confirm nVNS is stimulating the vagus nerve non-invasively and that nVNS can be effective in preventing menstrual migraine831
  6.25 Apr 01, 2016: NICE provides positive guidance on electroCore s gammaCore treatment for the prevention and acute treatment of migraine and cluster headache841
  6.26 Feb 29, 2016: Second Quarter Results ended December 31, 2015 - Ergoresearch reports its results for the quarter ended December 31, 2015851
  6.27 Feb 24, 2016: LivaNova Reports 2015 Annual and Fourth Quarter Financial Results853
  6.28 Jan 19, 2016: University of Bonn study shows that non-invasive vagus nerve stimulation (nVNS) device reduces number of migraine attacks and their intensity881
  6.29 Jan 06, 2016: ElectroCore Appoints Desitin to Launch gammaCore for the Treatment of Primary Headache across Germany891
  6.30 Jan 05, 2016: LivaNova Provides Update on FDA Warning Letter891
  6.31 Dec 23, 2015: Mittel Plans to Sell 6% Interest in LivaNova901
  6.32 Nov 19, 2015: Checkpoint Surgical Raises USD7.5 Million in Venture Financing901
  6.33 Nov 12, 2015: LivaNova Provides Business Update903
7 Appendix934
  7.1 Methodology932
  7.2 About GlobalData951
  7.3 Contact Us951
  7.4 Disclaimer961

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016" Nov 01, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData/Vagus-Nerve-Stimulators-Medical-Devices-Pipeline-Assessment-2016-2085-24044>
  
APA:
GlobalData. (2016). Vagus Nerve Stimulators - Medical Devices Pipeline Assessment, 2016 Nov 01, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData/Vagus-Nerve-Stimulators-Medical-Devices-Pipeline-Assessment-2016-2085-24044>
  
US$ 2,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.